Blackstone (BX) Stock Seems Reasonably Priced Following The ZO Skin Health Sale

Blackstone has seen its share price fall sharply this year, and that kind of slide raises a simple question for you as an investor. Is the current valuation still grounded in the returns the asset manager earns on the capital it puts to work across its funds and balance sheet. Year to date, Blackstone shares are down 30.7%, which puts fresh attention on whether the business is earning enough on its capital to support today's pricing. Recent deals and funding decisions, such as the planned...